The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Rabar, Antony
    Director born in September 1966
    Individual (4 offsprings)
    Officer
    2019-05-24 ~ now
    OF - director → CIF 0
    Mr Antony Rabar
    Born in September 1966
    Individual (4 offsprings)
    Person with significant control
    2022-09-01 ~ now
    PE - Has significant influence or control → CIF 0
  • 2
    Scott-barrett, Alexander John
    Company Director born in June 1955
    Individual (9 offsprings)
    Officer
    2019-10-15 ~ now
    OF - director → CIF 0
Ceased 4
  • 1
    Rabar, Antony
    Individual (4 offsprings)
    Officer
    2019-05-24 ~ 2022-10-10
    OF - secretary → CIF 0
    Mr Antony Rabar
    Born in September 1966
    Individual (4 offsprings)
    Person with significant control
    2019-10-20 ~ 2022-09-01
    PE - Has significant influence or control → CIF 0
  • 2
    Mr Alexander John Scott-barrett
    Born in June 1955
    Individual (9 offsprings)
    Person with significant control
    2022-10-10 ~ 2022-10-10
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 3
    Mr Christopher Teng-boon Tan
    Born in September 1980
    Individual (9 offsprings)
    Person with significant control
    2019-05-24 ~ 2019-10-20
    PE - Has significant influence or control → CIF 0
  • 4
    Curley, Edward Reid
    Technology Executive born in November 1966
    Individual
    Officer
    2023-06-01 ~ 2023-11-28
    OF - director → CIF 0
parent relation
Company in focus

TISSUE & CELL TECHNOLOGIES LIMITED

Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Intangible Assets
1,064 GBP2023-09-30
1,241 GBP2022-10-01
1,241 GBP2022-09-30
Property, Plant & Equipment
5,696 GBP2023-09-30
13,007 GBP2022-10-01
13,007 GBP2022-09-30
Amounts invested in assets
249,505 GBP2023-09-30
249,505 GBP2022-10-01
249,505 GBP2022-09-30
Debtors
378,769 GBP2023-09-30
376,357 GBP2022-09-30
Cash at bank and in hand
34,232 GBP2023-09-30
25,590 GBP2022-09-30
Current Assets
413,001 GBP2023-09-30
401,947 GBP2022-09-30
Creditors
Amounts falling due within one year
-3,298,023 GBP2023-09-30
-2,115,392 GBP2022-09-30
Net Current Assets/Liabilities
-2,885,022 GBP2023-09-30
-1,713,445 GBP2022-09-30
Total Assets Less Current Liabilities
-2,628,757 GBP2023-09-30
-1,449,692 GBP2022-09-30
Creditors
Amounts falling due after one year
-16,667 GBP2023-09-30
-26,667 GBP2022-09-30
Net Assets/Liabilities
-2,645,424 GBP2023-09-30
-1,476,359 GBP2022-09-30
Equity
Called up share capital
50,500 GBP2023-09-30
50,500 GBP2022-09-30
Share premium
49,500 GBP2023-09-30
49,500 GBP2022-09-30
Retained earnings (accumulated losses)
-2,745,424 GBP2023-09-30
-1,576,359 GBP2022-09-30
Equity
-2,645,424 GBP2023-09-30
-1,476,359 GBP2022-09-30
Average Number of Employees
122022-10-01 ~ 2023-09-30
122021-10-01 ~ 2022-09-30
Intangible Assets - Gross Cost
Other than goodwill
1,775 GBP2023-09-30
1,775 GBP2022-10-01
Intangible Assets - Gross Cost
1,775 GBP2023-09-30
1,775 GBP2022-10-01
Intangible Assets - Accumulated Amortisation & Impairment
Other than goodwill
711 GBP2023-09-30
534 GBP2022-10-01
Intangible Assets - Accumulated Amortisation & Impairment
711 GBP2023-09-30
534 GBP2022-10-01
Intangible Assets - Increase From Amortisation Charge for Year
Other than goodwill
177 GBP2022-10-01 ~ 2023-09-30
Intangible Assets - Increase From Amortisation Charge for Year
177 GBP2022-10-01 ~ 2023-09-30
Intangible Assets
Other than goodwill
1,064 GBP2023-09-30
1,241 GBP2022-10-01
Property, Plant & Equipment - Gross Cost
Plant and equipment
25,916 GBP2023-09-30
24,084 GBP2022-10-01
Property, Plant & Equipment - Gross Cost
25,916 GBP2023-09-30
24,084 GBP2022-10-01
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
20,220 GBP2023-09-30
11,077 GBP2022-10-01
Property, Plant & Equipment - Accumulated Depreciation & Impairment
20,220 GBP2023-09-30
11,077 GBP2022-10-01
Property, Plant & Equipment - Increase or decrease in depreciation and impairment
Plant and equipment
9,143 GBP2022-10-01 ~ 2023-09-30
Property, Plant & Equipment
Plant and equipment
5,696 GBP2023-09-30
13,007 GBP2022-10-01
  • TISSUE & CELL TECHNOLOGIES LIMITED
    Info
    Registered number 12015631
    Mountview Court, 1148 High Road, Whetstone, London N20 0RA
    Private Limited Company incorporated on 2019-05-24 (6 years). The company status is Liquidation.
    The last date of confirmation statement was made at 2024-03-01
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.